(IBGA) iShares iBonds Dec 2044 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: (N/A)

U.S. Treasury Securities, 2044, Target Maturity

Description: IBGA iShares iBonds Dec 2044

The iShares iBonds Dec2044 Term Treasury ETF (IBGA) is a targeted maturity ETF that focuses on investing in U.S. Treasury securities with maturities between January 1, 2044, and December 15, 2044. By concentrating on a specific maturity range, IBGA provides investors with a predictable income stream and a clear duration exposure.

The ETFs investment strategy involves tracking an underlying index composed of publicly issued U.S. Treasury securities that meet specific maturity criteria. This approach allows IBGA to maintain a consistent portfolio profile, minimizing the need for frequent rebalancing and enabling investors to better anticipate future cash flows.

Given the current market conditions and the ETFs characteristics, a closer examination of its technical and fundamental data reveals potential insights. The ETFs price is currently at $24.23, with short-term moving averages (SMA20 and SMA50) indicating a slight downward trend. The longer-term SMA200 suggests a stable foundation, but the overall trend is slightly bearish. The Average True Range (ATR) of 0.26 represents a 1.06% daily volatility, which is relatively moderate.

Combining the technical data with fundamental insights, such as the Assets Under Management (AUM) of $64.29M, we can infer that IBGA is a relatively small but focused investment vehicle. The AUM suggests that while the ETF is not among the largest, it still maintains a stable presence in the market.

Forecasting the ETFs future performance involves analyzing both technical and fundamental data. Based on the current SMA trends and ATR, a potential price movement could be anticipated. If the ETF continues to track its current trend, it may experience a slight decline or stabilization in the short term. However, considering the underlying indexs composition and the ETFs maturity focus, a more significant shift in the yield curve or interest rates could impact the ETFs performance. Assuming a stable interest rate environment, a potential target price for IBGA could be around $24.50 in the near term, representing a 1% increase from the current price. Nevertheless, this forecast is contingent upon various market factors, including changes in interest rates, economic conditions, and investor sentiment.

IBGA ETF Overview

Market Cap in USD 74m
Category Target Maturity
TER 0.07%
IPO / Inception 2024-06-11

IBGA ETF Ratings

Growth Rating 6.37%
Fundamental -
Dividend Rating 60.4%
Return 12m vs S&P 500 -18.6%
Analyst Rating -

IBGA Dividends

Dividend Yield 12m 4.35%
Yield on Cost 5y 4.50%
Annual Growth 5y 21.89%
Payout Consistency 100.0%
Payout Ratio %

IBGA Growth Ratios

Growth Correlation 3m 68.4%
Growth Correlation 12m -14.1%
Growth Correlation 5y -20.6%
CAGR 5y 4.47%
CAGR/Max DD 3y 0.38
CAGR/Mean DD 3y 0.67
Sharpe Ratio 12m -0.39
Alpha 0.00
Beta 0.416
Volatility 10.47%
Current Volume 9.9k
Average Volume 20d 12.2k
Stop Loss 24.5 (-3.3%)
Signal 0.50

What is the price of IBGA shares?

As of September 17, 2025, the stock is trading at USD 25.33 with a total of 9,895 shares traded.
Over the past week, the price has changed by +0.85%, over one month by +4.36%, over three months by +6.13% and over the past year by -3.37%.

Is iShares iBonds Dec 2044 a good stock to buy?

Neither. Based on ValueRay´s Analyses, iShares iBonds Dec 2044 is currently (September 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 6.37 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBGA is around 25.24 USD . This means that IBGA is currently overvalued and has a potential downside of -0.36%.

Is IBGA a buy, sell or hold?

iShares iBonds Dec 2044 has no consensus analysts rating.

What are the forecasts/targets for the IBGA price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 27.9 10.1%

Last update: 2025-09-12 04:38

IBGA Fundamental Data Overview

Market Cap USD = 74.4m (74.4m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 74.4m USD (74.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 74.4m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 74.4m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(74.4m)/V(0.0) * Re(7.55%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBGA ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle